Fig. 1 · Structure
Documents & Downloads
Asunercept
CD95L Inhibitor
Asunercept is a soluble CD95-Fc fusion protein (hIgG1) that selectively targets CD95L. By disrupting the CD95/CD95L signaling pathway, Asunercept modulates apoptosis and immune responses. This reagent is valuable for research into glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD).
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1450882-18-4 |
| Applications | CD95L Inhibitor |
| Molecular Weight | 84.05 kDa |
| Synonyms | APG101; CAN008 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.